Polydex Pharmaceuticals Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Polydex Pharmaceuticals Limited with three other
pharmaceutical manufacturers in North America:
sales of 6.21 million Canadian Dollars [US$4.96 million]
of the United States
Elite Pharmaceuticals, Inc.
based in the United States
of which 90%
During the year ended January of 2017, sales at
Polydex Pharmaceuticals Limited were C$8.70 million (US$6.95 million).
increase of 11.0%
versus 2016, when the company's sales were C$7.84 million.